Fate Therapeutics Inc

FATE NASDAQ Santé & Biotech États-Unis US31189P1021
2.08 $
10.10 %

Fate Therapeutics se focalise sur le développement de traitements immuno-oncologiques dérivés de cellules souches programmées pour combattre le cancer.

Price history of Fate Therapeutics Inc
Price history of Fate Therapeutics Inc

Performance & Momentum

6 Months 95.88 %
1 Year 88.12 %
3 Years 64.35 %
5 Years 97.52 %

Similar stocks to Fate Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone